- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1876-6250
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Optimal duration of dual antiplatelet therapy for coronary artery disease ; volume:26 ; number:6 ; day:30 ; month:4 ; year:2018 ; pages:321-333 ; date:6.2018
Netherlands heart journal ; 26, Heft 6 (30.4.2018), 321-333, 6.2018
- Creator
-
Kikkert, W. J.
- Contributor
-
Damman, P.
SpringerLink (Online service)
- DOI
-
10.1007/s12471-018-1113-5
- URN
-
urn:nbn:de:101:1-2018080500020704508995
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kikkert, W. J.
- Damman, P.
- SpringerLink (Online service)
Other Objects (12)
Dual Antiplatelet Therapy in Coronary Artery Disease
Duration of dual antiplatelet therapy after percutaneous coronary intervention of unprotected left main coronary artery stenosis: 6 versus 12 months
Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome
Impact of bleeding during dual antiplatelet therapy in patients with coronary artery disease
Comparison of dual antiplatelet therapies after coronary endarterectomy combined with coronary artery bypass grafting: a cohort study
Dual Antiplatelet or Dual Antithrombotic Therapy for Secondary Prevention in High-Risk Patients with Stable Coronary Artery Disease?
Outcomes with Longterm Dual Antiplatelet Therapy After Coronary Angioplasty
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention or after acute coronary syndrome : Practical lessons from a review
Dual antiplatelet therapy before coronary artery bypass grafting in patients with myocardial infarction: a prospective cohort study
Duration of dual antiplatelet therapy for patients at high bleeding risk undergoing PCI
Correction to: Real-World Dual Antiplatelet Therapy Following Polymer-Free Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease
Lower Antiplatelet Effect of Aspirin in Essential Thrombocythemia than in Coronary Artery Disease
Dual Antiplatelet Therapy in Coronary Artery Disease
Duration of dual antiplatelet therapy after percutaneous coronary intervention of unprotected left main coronary artery stenosis: 6 versus 12 months
Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome
Impact of bleeding during dual antiplatelet therapy in patients with coronary artery disease
Comparison of dual antiplatelet therapies after coronary endarterectomy combined with coronary artery bypass grafting: a cohort study
Dual Antiplatelet or Dual Antithrombotic Therapy for Secondary Prevention in High-Risk Patients with Stable Coronary Artery Disease?
Outcomes with Longterm Dual Antiplatelet Therapy After Coronary Angioplasty
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention or after acute coronary syndrome : Practical lessons from a review
Dual antiplatelet therapy before coronary artery bypass grafting in patients with myocardial infarction: a prospective cohort study
Duration of dual antiplatelet therapy for patients at high bleeding risk undergoing PCI
Correction to: Real-World Dual Antiplatelet Therapy Following Polymer-Free Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease
Lower Antiplatelet Effect of Aspirin in Essential Thrombocythemia than in Coronary Artery Disease
Dual Antiplatelet Therapy in Coronary Artery Disease
Duration of dual antiplatelet therapy after percutaneous coronary intervention of unprotected left main coronary artery stenosis: 6 versus 12 months
Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome
Impact of bleeding during dual antiplatelet therapy in patients with coronary artery disease
Comparison of dual antiplatelet therapies after coronary endarterectomy combined with coronary artery bypass grafting: a cohort study
Dual Antiplatelet or Dual Antithrombotic Therapy for Secondary Prevention in High-Risk Patients with Stable Coronary Artery Disease?
Outcomes with Longterm Dual Antiplatelet Therapy After Coronary Angioplasty
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention or after acute coronary syndrome : Practical lessons from a review
Dual antiplatelet therapy before coronary artery bypass grafting in patients with myocardial infarction: a prospective cohort study
Duration of dual antiplatelet therapy for patients at high bleeding risk undergoing PCI
Correction to: Real-World Dual Antiplatelet Therapy Following Polymer-Free Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease